Latest Breaking News On - Tempus ai inc - Page 2 : comparemela.com

Personalis, Inc. , a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent business.

United statesChris hallTempus ai incExchange commissionClearnote healthPersonalis incMedicare advantageTempus labsMyriad geneticsPersonali immunoChief executiveVeterans affairs million programFull yearConference callPrivate securities litigation reform actFinancial condition